Contact us at 1.800.501.7654 or info@biossusa.com
Browse research updates, product guides, grant news, and practical antibody workflow articles from Bioss.
For years, Alzheimer’s disease (AD) has remained a formidable challenge for patients, families, and researchers. One of the most heartbreaking realities for many is the phrase: “There is no cure.” Although several new treatments have emerged over the past few decades, options...
Read more
Alzheimer’s disease (AD) remains a devastating challenge, robbing millions worldwide of their memories and independence. For decades, treatments only addressed symptoms—until now. Enter Kisunla (donanemab-azbt), a groundbreaking therapy from Eli Lilly that targets the root cause of AD: toxic amyloid plaques in...
Read more
As the new school year starts, Bioss is excited to announce the launch of our Neuroscience Research Grant. This initiative aims to support students and educators in their research endeavors by providing financial assistance for projects that contribute to the advancement of knowledge...
Read more
Our Neuroscience Grant is back in support of Multiple Sclerosis Awareness Month! Submissions are open for all neuroscience-related projects and educational classes. See terms and conditions for more information.
Read more
The Alzheimer's Conundrum: Elusive Cures and Escalating Cases
Read more
Our Neuroscience Holiday Research Grant is no longer accepting applicants. Sign up for the Bioss Newsletter to be notified of the next one!
Read more
Understanding Neurodevelopmental Disorders: The Role of Assembloids
Read more
Site-Specific R-loops: A Promising New Approach for Treating Fragile X Syndrome
Read more
Are glia-to-neuron (GtN) conversions able to be accomplished by controlling the expression of a single or a combination of fate-determining factors?
Read more
Biomarkers: the road sign towards the cure of Alzhermer's Disease
Read more
biomarker of Alzheimer disease
Read more
